Out Of State Cog SCA denied as duplicate or overlapping therapy by Humana?

Humana's specific coverage criteria for out of state cog sca are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Out-of-State Cognitive/SCA Therapy as Duplicate Therapy

Humana's "duplicate therapy" denial applies when the plan determines that a service being requested is substantially equivalent to another service already being paid for, either concurrently or in close time proximity. For out-of-state cognitive rehabilitation or spinocerebellar ataxia (SCA) therapy, this denial often arises when Humana identifies a local in-network cognitive or neurological therapy provider already on claim, and concludes the out-of-state program duplicates that coverage.

## Why This Denial Is Appealable

The core rebuttal is clinical differentiation: the out-of-state program must be shown to provide a specialized, distinct intervention unavailable locally — not merely the same service delivered elsewhere. SCA and complex cognitive rehabilitation often require highly specialized interdisciplinary teams, disease-specific expertise, and program structures that standard local outpatient therapy cannot replicate. Your appeal should document what makes the out-of-state program clinically distinct and why local alternatives are inadequate.

Federal appeal framework: - ACA §2719 external review: Available after internal denial; an independent specialist reviews whether the services are genuinely duplicative. - ERISA §503: Entitles you to the plan's definition of "duplicate" and the specific comparison Humana made between the two services. - Timeline: Approximately 4 months from denial to request external review. Expedited review is available when delay would seriously harm your health.

## Appeal Process

1. Obtain the denial letter identifying which service Humana claims is a duplicate and the policy section cited. 2. Request from Humana the clinical criteria used to determine duplication. 3. Have the out-of-state provider supply a written differentiation letter explaining the unique elements of their program. 4. File internal appeal with clinical documentation of distinction; escalate to external review if denied.

## Documentation to Gather

• Detailed program description from the out-of-state facility highlighting disease-specific expertise, specialized techniques, and interdisciplinary components
• Treating neurologist or specialist letter explaining why local alternatives are clinically inadequate for the specific diagnosis
• Records from any local therapy showing its scope and what it does not address
• Diagnosis documentation confirming the complexity or rarity of the condition requiring specialized care
• Referral and evaluation records supporting the out-of-state program recommendation

## Criteria-Mapping Structure

From Humana's duplicate-therapy policy, list each criterion used to classify services as duplicative. For each criterion, provide a specific clinical fact from the record that distinguishes the out-of-state program — modality, intensity, specialization, and outcomes not available locally. The goal is to make the services look nothing alike when placed side by side.